Standout Papers
- Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. (1996)
Immediate Impact
2 by Nobel laureates 4 from Science/Nature 57 standout
Citing Papers
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs
2022 Standout
Works of Mitra Boolell being referenced
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
1996 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mitra Boolell | 798 | 1367 | 437 | 28 | 2.1k | |
| Jeremy P.W. Heaton | 1052 | 1488 | 407 | 77 | 2.8k | |
| Antonio Martín‐Morales | 1217 | 1662 | 581 | 39 | 2.0k | |
| Geoffrey Hackett | 1562 | 1143 | 353 | 72 | 2.3k | |
| Anthony J Bella | 832 | 1636 | 391 | 89 | 2.4k | |
| Ignacio Moncada | 1453 | 1935 | 456 | 89 | 2.8k | |
| David Ralph | 811 | 1312 | 441 | 91 | 2.3k | |
| Mustafa F. Usta | 829 | 1336 | 309 | 28 | 1.7k | |
| Michael Sweeney | 405 | 574 | 531 | 42 | 1.8k | |
| Muammer Kendirci | 780 | 1569 | 381 | 68 | 2.1k | |
| I Sáenz de Tejada | 1767 | 2260 | 399 | 32 | 3.1k |
All Works
Loading papers...